To augment IBO’s coverage of quarterly financial results, IBO will now provide sidebar summaries of results for companies not in the Sales Indexes.

Third quarter FEI sales grew 4.2%, 3.5% organically, to $218.5 million (see page 12), with acquisitions contributing 0.9% and currency lowering sales 0.2%. Industry sales grew 3.3%, 1.7% organically, to account for 47% of revenues. Semiconductor demand was partially offset by weak oil and gas, and mining sales. Science revenue grew 5.1%, 4.7% organically, to make up 53%, led by demand for structural and cell-biology solutions. Sales of lower-resolution systems partially offset segment revenue growth. Overall, sales in the US/Canada and Asia-Pacific/Rest of World grew 18.0% and 5.7% excluding currency to make up 34% and 41% of revenues, respectively. European sales fell 9.6% on a currency-neutral basis to make up 25%. Adjusted gross margin slipped 10 basis points to 47.8% of sales. Adjusted operating profit rose 5.5% to $35.9 million. FEI lowered its 2014 revenue-growth outlook by two percentage points to 3%–5% to $956–971 million as a result of currency and weakness in the Electronics business.

Hitachi High-Technologies’ fiscal second quarter 2015 Science and Medical Systems (SMS) sales grew 11.3% to ¥41.3 billion ($397.2 million = ¥103.99= $1) to account for 26% of revenues (see page 12). Excluding currency, SMS sales grew in the high single digits. Sales of Electron Microscopes climbed 19.2% to make up 23% of SMS revenue. Other Scientific Instruments sales slipped 1.5% to make up 15%. Sales of Medical products, and Biotechnology and Other products grew 13.8% and 3.0% to account for 54% and 8%, respectively. SMS fiscal 2015 revenue outlook was raised 4% to ¥156.7 billion ($1.48 billion = ¥106 = $1) for growth of 4.2% due to higher sales of clinical analyzers to emerging markets and higher US revenues, with Electron Microscopes sales expected to grow 7%, and Other Instrument sales projected to fall 4%. Fiscal 2015 SMS operating profit outlook was raised 28% to ¥21.4 billion ($202 million) for growth of 18%.

Third quarter sales for Mettler-Toledo’s Laboratory unit grew 6% on a reported and currency-neutral basis to account for 46% of revenues. Analytical Instruments, Automated Chemistry and Process Analytics drove sales. Benchtop-instrument sales grew in the double digits. Growth benefited from pricing and strong demand in the US and China.